Effect of Low Protein Diet on Top of Dapagliflozin on Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.
Also called NCT06281899
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 200 participants
- Sponsor
- Anemia Working Group Romania
- Registry
-
NCT06281899
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Romania
- Registry status
- Recruiting
Technical summary
Registry record NCT06281899. Randomized; no masking; primary purpose treatment. Start 2022-01-01 (actual); primary completion 2027-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Low Protein Diet on Top of Dapagliflozin on Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus
- Acronym
- PRODAPA-CKD
- Condition
- Chronic Kidney Diseases
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- Dapagliflozin 10 mg Tab
- Intervention (Behavioral)
- Low protein diet
- Lead sponsor
- Anemia Working Group Romania
- Collaborator
- Sf Ioan Emergency Clinical Hospital, Nephrology and Dialysis Department, Bucharest, Romania
- Collaborator
- Dr Carol Davila Teaching Hospital of Nephrology, Nephrology Department, Bucharest, Romania
- Collaborator
- Carol Davila University of Medicine and Pharmacy
Record details
- Record id
cardio:ct-nct06281899- Content hash
5c8e7e485bcee1ca5cf9e0767526de47de482dac9d60541c8f6aa2a9571e2997